Bipolar Disorder, Manic
9
0
0
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 67/100
22.2%
2 terminated out of 9 trials
75.0%
-11.6% vs benchmark
33%
3 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (9)
Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania
Study of Lumateperone in the Treatment of Patients With Bipolar Mania
Voice Changes During ECT
Magnetic Seizure Therapy for Bipolar Mania
Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder
Magnetic Seizure Therapy vs. Electroconvulsive Therapy for Bipolar Mania
Ziprasidone And Olanzapine's Outcomes In Mania
Ebselen as an add-on Treatment in Hypo/Mania
Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania